Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Vaccines

Free Subscription Articles published in JAMA Retrieve available abstracts of 151 articles: HTML format

Single Articles

November 2022
1. SLOMSKI A
   Intranasal COVID-19 Vaccine Disappointing in First-in-Human Trial.
   JAMA. 2022;328:2003.
   PubMed    
   
   
   
2. KUEHN BM
   Targeted Flu Vaccination Campaigns Needed for Certain Racial and Ethnic Groups.
   JAMA. 2022;328:2005.
   PubMed    
   
   
   
3. RUBIN R
   Vaccine Approved in Pregnancy to Protect Young Infants.
   JAMA. 2022;328:1898.
   PubMed    
   
   
   
4. LARKIN HD
   WHO Backs Single Dose of Hepatitis A Vaccine in Some Cases.
   JAMA. 2022;328:1896.
   PubMed    
   
   
   
5. LARKIN HD
   Studies Find Single Dose of HPV Vaccines May Be Effective.
   JAMA. 2022;328:1896.
   PubMed    
   
   
   
6. KUEHN BM
   Shifting Hepatitis A Epidemiology Requires Renewed Vaccination Efforts.
   JAMA. 2022;328:1800.
   PubMed    
   
   
   
7. KUEHN BM
   Single Monkeypox Vaccine Dose Provides Some Protection.
   JAMA. 2022;328:1801.
   PubMed    
   
   
   
8. KUEHN BM
   Second COVID-19 Booster Increases Protection for Nursing Home Patients.
   JAMA. 2022;328:1800-1801.
   PubMed    
   
   
   October 2022
9. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
   Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
   JAMA. 2022 Oct 21. pii: 2797483. doi: 10.1001/jama.2022.18590.
   PubMed     Abstract available
   
   
   
10. THOMPSON MG, Yoon SK, Naleway AL, Meece J, et al
    Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
    JAMA. 2022;328:1523-1533.
    PubMed     Abstract available
    
    
    
11. BELLANDI D
    Rotavirus Leads Global Diarrhea Hospitalizations Among Young Children.
    JAMA. 2022;328:1490.
    PubMed    
    
    
    
12. LARKIN HD
    Progress on Replication-Defective Live Virus Vaccines.
    JAMA. 2022;328:1387.
    PubMed    
    
    
    
13. KUEHN BM
    Catch-up Vaccinations Needed for Some Adolescents.
    JAMA. 2022;328:1389-1390.
    PubMed    
    
    
    
14. ABBASI J
    White House Advisor Nahid Bhadelia, MD, MALD, on COVID-19 in Resource-Limited Nations-Undercounted Deaths, Vaccine Inequity, and More.
    JAMA. 2022 Oct 5. pii: 2797281. doi: 10.1001/jama.2022.13663.
    PubMed    
    
    
    September 2022
15. HAZRA A, Rusie L, Hedberg T, Schneider JA, et al
    Human Monkeypox Virus Infection in the Immediate Period After Receiving Modified Vaccinia Ankara Vaccine.
    JAMA. 2022 Sep 30. pii: 2797135. doi: 10.1001/jama.2022.18320.
    PubMed    
    
    
    
16. KELLY JD, Leonard S, Hoggatt KJ, Boscardin WJ, et al
    Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.
    JAMA. 2022 Sep 26. pii: 2796892. doi: 10.1001/jama.2022.17985.
    PubMed     Abstract available
    
    
    
17. TENFORDE MW, Link-Gelles R, Patel MM
    Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.
    JAMA. 2022 Sep 26. pii: 2796894. doi: 10.1001/jama.2022.14660.
    PubMed    
    
    
    
18. LIN DY, Gu Y, Xu Y, Wheeler B, et al
    Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes.
    JAMA. 2022 Sep 26. pii: 2796893. doi: 10.1001/jama.2022.17876.
    PubMed     Abstract available
    
    
    
19. RIDGWAY JP, Tideman S, French T, Wright B, et al
    Odds of Hospitalization for COVID-19 After 3 vs 2 Doses of mRNA COVID-19 Vaccine by Time Since Booster Dose.
    JAMA. 2022 Sep 23. pii: 2796847. doi: 10.1001/jama.2022.17811.
    PubMed    
    
    
    
20. RUBIN R
    The Dreaded "Twindemic" of Influenza and COVID-19 Has Not Yet Materialized-Might This Be the Year?
    JAMA. 2022 Sep 21. pii: 2796806. doi: 10.1001/jama.2022.15062.
    PubMed    
    
    
    
21. LARKIN HD
    Backslide in Global Childhood Vaccinations.
    JAMA. 2022;328:1029.
    PubMed    
    
    
    
22. LARKIN HD
    New Data on Heterologous COVID-19 Vaccine Combinations.
    JAMA. 2022;328:916-917.
    PubMed    
    
    
    
23. LARKIN HD
    FDA Authorizes Intradermal Vaccine, Streamlines Rules to Increase Monkeypox Treatment Access.
    JAMA. 2022;328:819.
    PubMed    
    
    
    
24. CULLEN JP, Russ S, Russell HA
    Theater for Vaccine Hesitancy-Setting the Stage for Difficult Conversations.
    JAMA. 2022 Sep 2. pii: 2796160. doi: 10.1001/jama.2022.14864.
    PubMed    
    
    
    August 2022
25. BARNETT ML, Waken RJ, Zheng J, Orav EJ, et al
    Changes in Health and Quality of Life in US Skilled Nursing Facilities by COVID-19 Exposure Status in 2020.
    JAMA. 2022 Aug 29. pii: 2795935. doi: 10.1001/jama.2022.15071.
    PubMed     Abstract available
    
    
    
26. RUBIN R
    Despite Its Fan Base, Newly Authorized "Traditional" Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US.
    JAMA. 2022 Aug 24. pii: 2795814. doi: 10.1001/jama.2022.13661.
    PubMed    
    
    
    
27. LO RE V 3RD, Dutcher SK, Connolly JG, Perez-Vilar S, et al
    Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
    JAMA. 2022;328:637-651.
    PubMed     Abstract available
    
    
    
28. LARKIN HD
    New "Universal" Flu Vaccine Candidate Enters Clinical Trial.
    JAMA. 2022;328:518.
    PubMed    
    
    
    
29. KUEHN BM
    More Effective Flu Vaccines Recommended for Older Adults.
    JAMA. 2022;328:519.
    PubMed    
    
    
    July 2022
30. KIM YE, Huh K, Park YJ, Peck KR, et al
    Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2022 Jul 22. pii: 2794753. doi: 10.1001/jama.2022.12992.
    PubMed    
    
    
    
31. LARKIN HD
    Mix-and-Match COVID-19 Boosters After Inactivated Virus Vaccine.
    JAMA. 2022;328:234.
    PubMed    
    
    
    
32. KUEHN BM
    Newer Poxvirus Vaccine Is Recommended.
    JAMA. 2022;328:123.
    PubMed    
    
    
    
33. RUBIN R
    COVID-19 Boosters This Fall to Include Omicron Antigen, but Questions Remain About Its Value.
    JAMA. 2022 Jul 8. pii: 2794259. doi: 10.1001/jama.2022.11252.
    PubMed    
    
    
    
34. AZZOLINI E, Levi R, Sarti R, Pozzi C, et al
    Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers.
    JAMA. 2022 Jul 1. pii: 2794072. doi: 10.1001/jama.2022.11691.
    PubMed    
    
    
    June 2022
35. ABBASI J
    COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies.
    JAMA. 2022 Jun 22. pii: 2793740. doi: 10.1001/jama.2022.11145.
    PubMed    
    
    
    
36. LARKIN HD
    mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
    JAMA. 2022;327:2280.
    PubMed    
    
    
    
37. LARKIN HD
    Maternal RSV Vaccine Could Protect Infants, Interim Analysis Suggests.
    JAMA. 2022;327:2182.
    PubMed    
    
    
    
38. KATZ SE, Edwards K
    Protecting Children Against Omicron.
    JAMA. 2022;327:2195-2197.
    PubMed    
    
    
    
39. JONES JM, Opsomer JD, Stone M, Benoit T, et al
    Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.
    JAMA. 2022 Jun 13. pii: 2793517. doi: 10.1001/jama.2022.9745.
    PubMed    
    
    
    
40. LI Y
    Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave.
    JAMA. 2022;327:2147-2148.
    PubMed    
    
    
    
41. TAI CG, Maragakis LL, Connolly S, DiFiori J, et al
    Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.
    JAMA. 2022 Jun 2. pii: 2793169. doi: 10.1001/jama.2022.9479.
    PubMed    
    
    
    
42. RUBIN R
    Challenges of Deciding Whether and How to Update COVID-19 Vaccines to Protect Against Variants.
    JAMA. 2022 Jun 1. pii: 2793149. doi: 10.1001/jama.2022.9367.
    PubMed    
    
    
    May 2022
43. WEISS SR
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
    JAMA. 2022;327:2019-2020.
    PubMed    
    
    
    
44. OSTER ME, Shay DK, Shimabukuro TT
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
    JAMA. 2022;327:2020-2021.
    PubMed    
    
    
    
45. KUEHN BM
    Cardiac Complications More Common After COVID-19 Than Vaccination.
    JAMA. 2022;327:1951.
    PubMed    
    
    
    
46. FLEMING-DUTRA KE, Britton A, Shang N, Derado G, et al
    Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
    JAMA. 2022 May 13. pii: 2792524. doi: 10.1001/jama.2022.7493.
    PubMed     Abstract available
    
    
    
47. DORABAWILA V, Hoefer D, Bauer UE, Bassett MT, et al
    Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.
    JAMA. 2022 May 13. pii: 2792525. doi: 10.1001/jama.2022.7319.
    PubMed    
    
    
    
48. LARKIN HD
    Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3.
    JAMA. 2022;327:1748.
    PubMed    
    
    
    
49. LARKIN HD
    Two mRNA COVID-19 Vaccines Stimulate Different Immune Responses.
    JAMA. 2022;327:1748.
    PubMed    
    
    
    
50. KUEHN BM
    Age Range Is Expanded for Universal Hepatitis B Vaccination.
    JAMA. 2022;327:1749.
    PubMed    
    
    
    
51. KUEHN BM
    mRNA Booster Improves a COVID-19 Vaccine's Effectiveness.
    JAMA. 2022;327:1749.
    PubMed    
    
    
    
52. SLOMSKI A
    Studies Examine Risk of Hearing Loss After COVID-19 Vaccination.
    JAMA. 2022;327:1641.
    PubMed    
    
    
    
53. MARKS P, Woodcock J, Califf R
    COVID-19 Vaccination-Becoming Part of the New Normal.
    JAMA. 2022 May 2. pii: 2792030. doi: 10.1001/jama.2022.7469.
    PubMed    
    
    
    April 2022
54. KUEHN BM
    COVID-19 Vaccine Effectiveness in Youth Varies by Age, Variant.
    JAMA. 2022;327:1540.
    PubMed    
    
    
    
55. RAZZAGHI H, Meghani M, Crane B, Ellington S, et al
    Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key Demographics.
    JAMA. 2022 Apr 22. pii: 2791659. doi: 10.1001/jama.2022.6834.
    PubMed    
    
    
    
56. LARKIN HD
    Fractionating COVID-19 Vaccine Doses May Save Lives.
    JAMA. 2022;327:1438.
    PubMed    
    
    
    
57. WOLFSON AR, Freeman EE, Blumenthal KG
    Urticaria 12 Days After COVID-19 mRNA Booster Vaccination.
    JAMA. 2022 Apr 14. pii: 2791317. doi: 10.1001/jama.2022.5247.
    PubMed    
    
    
    
58. ABBASI J
    Large US Study Examines First 6 Months of COVID-19 Vaccine Safety Data.
    JAMA. 2022;327:1323.
    PubMed    
    
    
    
59. ABBASI J
    Vaccine Booster Dose Appears to Reduce Omicron Hospitalizations.
    JAMA. 2022;327:1323.
    PubMed    
    
    
    
60. KUEHN BM
    Myocarditis Adverse Event Less Common After COVID-19 Vaccine Booster.
    JAMA. 2022;327:1324.
    PubMed    
    
    
    
61. SLOMSKI A
    Maternal COVID-19 Vaccine Safe for Infants.
    JAMA. 2022;327:1218.
    PubMed    
    
    
    
62. NISSEN SE, Wolski K, Balog C, Swerdlow DI, et al
    Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
    JAMA. 2022 Apr 3. pii: 2790912. doi: 10.1001/jama.2022.5050.
    PubMed     Abstract available
    
    
    
63. NATTINO G, Castiglioni S, Cereda D, Della Valle PG, et al
    Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021.
    JAMA. 2022 Apr 1. pii: 2790911. doi: 10.1001/jama.2022.4908.
    PubMed    
    
    
    March 2022
64. BRUXVOORT K, Slezak J, Qian L, Sy LS, et al
    Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
    JAMA. 2022 Mar 25. pii: 2790492. doi: 10.1001/jama.2022.2540.
    PubMed     Abstract available
    
    
    
65. KHARBANDA EO, Vazquez-Benitez G
    COVID-19 mRNA Vaccines During Pregnancy: New Evidence to Help Address Vaccine Hesitancy.
    JAMA. 2022 Mar 24. pii: 2790610. doi: 10.1001/jama.2022.2459.
    PubMed    
    
    
    
66. MAGNUS MC, Ortqvist AK, Dahlqwist E, Ljung R, et al
    Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes.
    JAMA. 2022 Mar 24. pii: 2790608. doi: 10.1001/jama.2022.3271.
    PubMed     Abstract available
    
    
    
67. FELL DB, Dhinsa T, Alton GD, Torok E, et al
    Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes.
    JAMA. 2022 Mar 24. pii: 2790607. doi: 10.1001/jama.2022.4255.
    PubMed     Abstract available
    
    
    
68. SLOMSKI A
    Pneumococcal Vaccine Induces Immune Responses to 20 Serotypes.
    JAMA. 2022;327:1118.
    PubMed    
    
    
    
69. STEAD W
    One Person.
    JAMA. 2022;327:1131-1132.
    PubMed    
    
    
    
70. FRIEDENSOHN L, Levin D, Fadlon-Derai M, Gershovitz L, et al
    Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel.
    JAMA. 2022 Mar 17. pii: 2790421. doi: 10.1001/jama.2022.4425.
    PubMed    
    
    
    
71. ABBASI J
    First mRNA HIV Vaccine Clinical Trial Launches.
    JAMA. 2022;327:909.
    PubMed    
    
    
    
72. KUEHN BM
    Racial and Ethnic, Gender Disparities Seen in LGBT COVID-19 Vaccination Rates.
    JAMA. 2022;327:910.
    PubMed    
    
    
    February 2022
73. ABBASI J
    Widespread Misinformation About Infertility Continues to Create COVID-19 Vaccine Hesitancy.
    JAMA. 2022 Feb 22. pii: 2789477. doi: 10.1001/jama.2022.2404.
    PubMed    
    
    
    
74. KUEHN BM
    New COVID-19 Vaccine Aims to Increase Global Vaccine Access.
    JAMA. 2022;327:614.
    PubMed    
    
    
    
75. KUEHN BM
    COVID-19 Vaccines Safe, Effective in Rheumatic Diseases.
    JAMA. 2022;327:614.
    PubMed    
    
    
    
76. BRITTON A, Fleming-Dutra KE, Shang N, Smith ZR, et al
    Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
    JAMA. 2022 Feb 14. pii: 2789294. doi: 10.1001/jama.2022.2068.
    PubMed     Abstract available
    
    
    
77. TAN SHX, Pung R, Wang LF, Lye DC, et al
    Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore.
    JAMA. 2022 Feb 11. pii: 2789151. doi: 10.1001/jama.2022.1922.
    PubMed    
    
    
    
78. ABBASI J
    Fourth COVID-19 Vaccine Dose Increases Low Antibodies.
    JAMA. 2022;327:517.
    PubMed    
    
    
    
79. KUEHN BM
    Health Care Professionals' Advice Can Increase COVID-19 Vaccination.
    JAMA. 2022;327:518.
    PubMed    
    
    
    
80. SHOOK LL, Atyeo CG, Yonker LM, Fasano A, et al
    Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection.
    JAMA. 2022 Feb 7. pii: 2788986. doi: 10.1001/jama.2022.1206.
    PubMed    
    
    
    January 2022
81. SURAN M
    Coverage of COVID-19 Vaccine Counseling for Children and Youths.
    JAMA. 2022;327:313.
    PubMed    
    
    
    
82. LI HF, Hu SM, Lv M
    Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome.
    JAMA. 2022;327:392-393.
    PubMed    
    
    
    
83. WOO EJ, Dimova RB, Mba-Jonas A
    Presumptive Guillain-Barre Syndrome Associated With Receipt of the Ad26.COV2.2.S COVID-19 Vaccine-Reply.
    JAMA. 2022;327:393-394.
    PubMed    
    
    
    
84. OSTER ME, Shay DK, Su JR, Gee J, et al
    Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
    JAMA. 2022;327:331-340.
    PubMed     Abstract available
    
    
    
85. KLOMPAS M, Karan A
    Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron Variant.
    JAMA. 2022 Jan 24. pii: 2788503. doi: 10.1001/jama.2022.0262.
    PubMed    
    
    
    
86. ABBASI J, Rubin R, Suran M
    How the Supreme Court's COVID-19 Vaccine Mandate Rulings Could Shape the Pandemic's Next Phase.
    JAMA. 2022 Jan 21. pii: 2788486. doi: 10.1001/jama.2022.0791.
    PubMed    
    
    
    
87. OMER SB, Malani PN
    Booster Vaccination to Prevent COVID-19 in the Era of Omicron: An Effective Part of a Layered Public Health Approach.
    JAMA. 2022 Jan 21. pii: 2788487. doi: 10.1001/jama.2022.0892.
    PubMed    
    
    
    
88. GOSTIN LO, Parmet WE, Rosenbaum S
    The US Supreme Court's Rulings on Large Business and Health Care Worker Vaccine Mandates: Ramifications for the COVID-19 Response and the Future of Federal Public Health Protection.
    JAMA. 2022 Jan 21. pii: 2788481. doi: 10.1001/jama.2022.0852.
    PubMed    
    
    
    
89. ACCORSI EK, Britton A, Fleming-Dutra KE, Smith ZR, et al
    Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    JAMA. 2022 Jan 21. pii: 2788485. doi: 10.1001/jama.2022.0470.
    PubMed     Abstract available
    
    
    
90. WANG L, Davis PB, Kaelber DC, Volkow ND, et al
    Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period.
    JAMA. 2022 Jan 20. pii: 2788408. doi: 10.1001/jama.2022.0210.
    PubMed    
    
    
    
91. KUEHN BM
    Vaccine Development Is Charting a New Path in Malaria Control.
    JAMA. 2022 Jan 19. pii: 2788387. doi: 10.1001/jama.2021.20627.
    PubMed    
    
    
    
92. KUEHN BM
    Vaccine Passports Help Boost Lagging Vaccination Rates.
    JAMA. 2022;327:209.
    PubMed    
    
    
    
93. ADASHI EY, Cohen IG
    The Pandemic Preparedness Program: Reimagining Public Health.
    JAMA. 2022;327:219-220.
    PubMed    
    
    
    
94. ABBASI J
    Former Biden-Harris Transition Advisors Propose a New National Strategy for COVID-19.
    JAMA. 2022 Jan 18. pii: 2788316. doi: 10.1001/jama.2022.0216.
    PubMed    
    
    
    
95. RUBIN R
    COVID-19 Vaccines Have Been Available in the US for More Than a Year-What's Been Learned and What's Next?
    JAMA. 2022 Jan 11. pii: 2788213. doi: 10.1001/jama.2022.0106.
    PubMed    
    
    
    
96. ABBASI J
    Studies Suggest COVID-19 Vaccine Boosters Save Lives.
    JAMA. 2022;327:115.
    PubMed    
    
    
    
97. ABBASI J
    Homing In On a SARS-CoV-2 Correlate of Protection.
    JAMA. 2022;327:115.
    PubMed    
    
    
    
98. ABBASI J
    COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial.
    JAMA. 2022;327:115.
    PubMed    
    
    
    
99. WALD A
    Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection.
    JAMA. 2022 Jan 10. pii: 2788105. doi: 10.1001/jama.2021.23726.
    PubMed    
    
    
    
100. SPITZER A, Angel Y, Marudi O, Zeltser D, et al
     Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
     JAMA. 2022 Jan 10. pii: 2788104. doi: 10.1001/jama.2021.23641.
     PubMed     Abstract available
     
     
     
101. BORIO LL, Bright RA, Emanuel EJ
     A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.
     JAMA. 2022 Jan 6. pii: 2787946. doi: 10.1001/jama.2021.24165.
     PubMed    
     
     
     December 2021
102. ABBASI J
     RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths.
     JAMA. 2021 Dec 29. pii: 2787757. doi: 10.1001/jama.2021.23772.
     PubMed    
     
     
     
103. 
     Two New Pneumococcal Vaccines-Prevnar 20 and Vaxneuvance.
     JAMA. 2021;326:2521-2522.
     PubMed    
     
     
     
104. SLOMSKI A
     More Pediatric Data for First Cell-Derived Influenza Vaccine.
     JAMA. 2021;326:2464.
     PubMed    
     
     
     
105. KUEHN BM
     Influenza Vaccination Increased During the COVID-19 Pandemic.
     JAMA. 2021;326:2465.
     PubMed    
     
     
     
106. ABBASI J
     Omicron Has Reached the US-Here's What Infectious Disease Experts Know About the Variant.
     JAMA. 2021;326:2460-2462.
     PubMed    
     
     
     
107. LAM DL, Flanagan MR
     Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer.
     JAMA. 2021 Dec 23. pii: 2787650. doi: 10.1001/jama.2021.20010.
     PubMed    
     
     
     
108. DEL RIO C, Omer SB, Malani PN
     Winter of Omicron-The Evolving COVID-19 Pandemic.
     JAMA. 2021 Dec 22. pii: 2787609. doi: 10.1001/jama.2021.24315.
     PubMed    
     
     
     
109. KUEHN BM
     Vaccination Doesn't Eliminate Delta Variant Household Transmission.
     JAMA. 2021;326:2353.
     PubMed    
     
     
     
110. COHN AC, Mahon BE, Walensky RP
     One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality.
     JAMA. 2021 Dec 21. pii: 2787504. doi: 10.1001/jama.2021.23962.
     PubMed    
     
     
     
111. LEVY M, Recher M, Hubert H, Javouhey E, et al
     Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France.
     JAMA. 2021 Dec 20. pii: 2787495. doi: 10.1001/jama.2021.23262.
     PubMed    
     
     
     
112. ADAMS LE, Waterman S, Paz-Bailey G
     Vaccination for Dengue Prevention.
     JAMA. 2021 Dec 16. pii: 2787445. doi: 10.1001/jama.2021.23466.
     PubMed    
     
     
     
113. BATES TA, McBride SK, Winders B, Schoen D, et al
     Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection.
     JAMA. 2021 Dec 16. pii: 2787447. doi: 10.1001/jama.2021.22898.
     PubMed    
     
     
     
114. SURAN M
     Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19.
     JAMA. 2021 Dec 15. pii: 2787289. doi: 10.1001/jama.2021.21625.
     PubMed    
     
     
     
115. ABBASI J
     COVID-19 Vaccine Combination Was Superior in Real-world Study.
     JAMA. 2021;326:2250.
     PubMed    
     
     
     
116. WALTER K
     COVID-19 and Pregnancy.
     JAMA. 2021 Dec 10. pii: 2787240. doi: 10.1001/jama.2021.22679.
     PubMed    
     
     
     
117. 
     Current Comment.
     JAMA. 2021;326:2217.
     PubMed    
     
     
     
118. GRUNAU B, Goldfarb DM, Asamoah-Boaheng M, Golding L, et al
     Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals.
     JAMA. 2021 Dec 3. pii: 2786992. doi: 10.1001/jama.2021.21921.
     PubMed    
     
     
     
119. ABBASI J
     Data Emerge From the UK's COVID-19 Vaccine Extended Dosing Interval.
     JAMA. 2021 Dec 3. pii: 2786993. doi: 10.1001/jama.2021.21963.
     PubMed    
     
     
     
120. FERNANDES B, Navin MC, Reiss DR, Omer SB, et al
     US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates.
     JAMA. 2021 Dec 2. pii: 2786984. doi: 10.1001/jama.2021.22122.
     PubMed    
     
     
     November 2021
121. RUBIN R
     COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed.
     JAMA. 2021 Nov 24. pii: 2786818. doi: 10.1001/jama.2021.21291.
     PubMed    
     
     
     
122. RUBIN R
     Substance Use Disorders and COVID-19 Vaccine Response.
     JAMA. 2021;326:2000.
     PubMed    
     
     
     
123. KUEHN BM
     COVID-19 Vaccine Highly Effective Against Adolescent Hospitalizations.
     JAMA. 2021;326:2002.
     PubMed    
     
     
     
124. KUEHN BM
     Unhygienic Practices Lead to Routine Vaccination-Linked Infections.
     JAMA. 2021;326:2002.
     PubMed    
     
     
     
125. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
     Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
     JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
     PubMed    
     
     
     
126. SFEIR MM, Snayd M
     Serologic Testing for Hepatitis B.
     JAMA. 2021 Nov 19. pii: 2786654. doi: 10.1001/jama.2021.19803.
     PubMed    
     
     
     
127. CHOR J, Davis AM, Rusiecki JM
     Cervical Cancer Screening Guideline for Individuals at Average Risk.
     JAMA. 2021 Nov 12. pii: 2786400. doi: 10.1001/jama.2021.13448.
     PubMed    
     
     
     
128. ABBASI J
     Flu Vaccine Candidate Elicits Enhanced Immune Response.
     JAMA. 2021;326:1784.
     PubMed    
     
     
     
129. ABBASI J
     Pfizer Launches Phase 1 mRNA Flu Vaccine Trial.
     JAMA. 2021;326:1784.
     PubMed    
     
     
     
130. ABBASI J
     "Polymutant" Spike Points Way Toward More Durable COVID-19 Vaccine.
     JAMA. 2021;326:1784.
     PubMed    
     
     
     
131. 
     Routine Smallpox Vaccination.
     JAMA. 2021;326:1876.
     PubMed    
     
     
     
132. ELIAKIM-RAZ N, Leibovici-Weisman Y, Stemmer A, Ness A, et al
     Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged >/=60 Years.
     JAMA. 2021 Nov 5. pii: 2786096. doi: 10.1001/jama.2021.19885.
     PubMed    
     
     
     
133. MOSS WJ, Gostin LO, Nuzzo JB
     Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know.
     JAMA. 2021 Nov 5. pii: 2786095. doi: 10.1001/jama.2021.20734.
     PubMed    
     
     
     
134. KLOMPAS M
     Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination.
     JAMA. 2021 Nov 4. pii: 2786040. doi: 10.1001/jama.2021.19063.
     PubMed    
     
     
     
135. TENFORDE MW, Self WH, Adams K, Gaglani M, et al
     Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
     JAMA. 2021 Nov 4. pii: 2786039. doi: 10.1001/jama.2021.19499.
     PubMed     Abstract available
     
     
     
136. CROWE EH
     The Taste of Hope.
     JAMA. 2021;326:1683-1684.
     PubMed    
     
     
     
137. ZHONG D, Xiao S, Debes AK, Egbert ER, et al
     Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection.
     JAMA. 2021 Nov 1. pii: 2785919. doi: 10.1001/jama.2021.19996.
     PubMed    
     
     
     
138. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
     Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
     JAMA. 2021 Nov 1. pii: 2785918. doi: 10.1001/jama.2021.19623.
     PubMed     Abstract available
     
     
     October 2021
139. ABBASI J
     The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
     JAMA. 2021 Oct 21. pii: 2785530. doi: 10.1001/jama.2021.18919.
     PubMed    
     
     
     
140. RUBIN R
     Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines.
     JAMA. 2021 Oct 14. pii: 2785303. doi: 10.1001/jama.2021.18143.
     PubMed    
     
     
     
141. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
     Changes in COVID-19 Vaccine Intent From April/May to June/July 2021.
     JAMA. 2021 Oct 13. pii: 2785290. doi: 10.1001/jama.2021.18761.
     PubMed    
     
     
     
142. ABBASI J
     India's New COVID-19 DNA Vaccine for Adolescents and Adults Is a First.
     JAMA. 2021;326:1365.
     PubMed    
     
     
     
143. ABBASI J
     Moderna's mRNA Vaccine for Seasonal Flu Enters Clinical Trials.
     JAMA. 2021;326:1365.
     PubMed    
     
     
     
144. ABBASI J
     Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
     JAMA. 2021;326:1365.
     PubMed    
     
     
     
145. KUEHN BM
     HPV Vaccination Coverage Has Increased Among Adolescents.
     JAMA. 2021;326:1366.
     PubMed    
     
     
     
146. WOO EJ, Mba-Jonas A, Dimova RB, Alimchandani M, et al
     Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome, February-July 2021.
     JAMA. 2021 Oct 7. pii: 2785009. doi: 10.1001/jama.2021.16496.
     PubMed     Abstract available
     
     
     September 2021
147. RUBIN R
     COVID-19 Vaccine Nasal Spray.
     JAMA. 2021;326:1138.
     PubMed    
     
     
     
148. KRONMAL SL
     Shots in Arms.
     JAMA. 2021;326:1151-1152.
     PubMed    
     
     
     August 2021
149. RUBIN R
     Influenza's Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store.
     JAMA. 2021 Aug 25. pii: 2783644. doi: 10.1001/jama.2021.14131.
     PubMed    
     
     
     
150. DETSKY AS, Bogoch II
     COVID-19 in Canada: Experience and Response to Waves 2 and 3.
     JAMA. 2021 Aug 23. pii: 2783610. doi: 10.1001/jama.2021.14797.
     PubMed    
     
     
     
151. DEL RIO C, Malani PN, Omer SB
     Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
     JAMA. 2021 Aug 18. pii: 2783478. doi: 10.1001/jama.2021.14811.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: